Hemenway Trust Hemenway Trust’s Novo Nordisk NVO Stock Holding History

Hemenway Trust Hemenway Trust’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$441K	Sell	11,999 -6,091	-34%	-$289K	0.04%	86
2025 Q4	$920K	Sell	18,090 -60,077	-77%	-$3.07M	0.07%	65
2025 Q3	$4.34M	Sell	78,167 -45,561	-37%	-$2.67M	0.33%	42
2025 Q2	$8.54M	Buy	123,728 +60,648	+96%	+$4.13M	0.66%	36
2025 Q1	$4.38M	Buy	63,080 +52,324	+486%	+$4.32M	0.36%	43
2024 Q4	$925K	Sell	10,756 -200	-2%	-$21.6K	0.08%	65
2024 Q3	$1.3M	Sell	10,956 -432	-4%	-$57.6K	0.1%	60
2024 Q2	$1.63M	Hold	11,388	–	–	0.14%	53
2024 Q1	$1.46M	Hold	11,388	–	–	0.13%	54
2023 Q4	$1.18M	Buy	11,388 +1,818	+19%	+$180K	0.11%	57
2023 Q3	$870K	Sell	9,570 -234	-2%	-$20.6K	0.09%	69
2023 Q2	$793K	Buy	9,804 +5,790	+144%	+$473K	0.08%	75
2023 Q1	$319K	Hold	4,014	–	–	0.03%	109
2022 Q4	$272K	Buy	+4,014	New	+$235K	0.03%	119
2016 Q1	–	Sell	-7,084	Closed	-$206K	–	151
2015 Q4	$206K	Sell	7,084 -940	-12%	-$26K	0.05%	149
2015 Q3	$218K	Buy	+8,024	New	+$227K	0.06%	146

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Hemenway Trust Hemenway Trust's NVO Position: Q1 2026 in Review

Hemenway Trust Hemenway Trust reduced its Novo Nordisk (NVO) stake by 34% in Q1 2026, selling an estimated $289K and leaving 11,999 shares worth $441K. The position accounts for 0.04% of the portfolio, ranked #86.

Hemenway Trust Hemenway Trust first reported a position in NVO in Q3 2015 and has held it in 16 quarters since. The position peaked at $8.54M in Q2 2025. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Hemenway Trust Hemenway Trust held 11,999 shares of Novo Nordisk worth $441K as of Q1 2026.
Hemenway Trust Hemenway Trust sold 6,091 Novo Nordisk shares in Q1 2026, an estimated $289K.
Novo Nordisk made up 0.04% of Hemenway Trust Hemenway Trust's portfolio in Q1 2026, its #86 holding.
Hemenway Trust Hemenway Trust first reported a position in Novo Nordisk in Q3 2015 and has held it in 16 quarters since.
Hemenway Trust Hemenway Trust's Novo Nordisk position peaked at $8.54M in Q2 2025.
1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Hemenway Trust Hemenway Trust's 13F filing for Q1 2026, filed 7 May 2026.